Implantate Extends Contracts of All Board Members

Implantate AG, a global medical device company focused on trauma products and biomaterials for the orthopedic market, has extended the existing contracts of their three executive board members for another three years until the end of the financial year 2015.

Advertisement

“We are glad to have accomplished the extension of the executive management contracts. With this successful team, we are able to further implement our focus strategy and concentrate on value creation as well as sustainable and profitable growth,” said Rubino di Girolamo, chairman of the supervisory board.

More Articles on Orthopedic Devices:

Spinal Elements to Donate Allograft Proceeds to Charity

Medtronic Launches Complementary Instrument Set for BRYAN Cervical Disc

SkelRegen Forms With Focus on Musculoskeletal Care

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.